IMVT
ImmunovantANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
IMVT vs peer average
80/100
IMVT vs. peer average (A vs. C)
Grade spread
A 2 · B 1 · C 2 · D 4
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
CELC is the first available peer comparator.
Closest size-and-stage comp: a mid-cap clinical biotech where valuation is primarily driven by program data readouts, safety, and trial execution rather than current earnings power.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMVT
Immunovant
CELC
Celcuity
Grade
A
A
Momentum
87
84
Value
41
41
Sentiment
66
78
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CELC
IMVT / CELC
Grade Position
Above peers
IMVT vs. peer average (A vs. C)
80/100
Momentum
87
IMVTValue
41
IMVTSentiment
66
CELCRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMVT
CELC is the first peer returned for this comparison set.